Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development

Oncogene

Volumn 32, Issue 20, 2013, Pages 2499-2509

  Chevet, E ^a,b   Fessart, D ^c   Delom, F ^c   Mulot, A ^a,b   Vojtesek, B ^d   Hrstka, R ^d   Murray, E ^d,e   Gray, T ^e   Hupp, T ^e  

^a INSERM U1053 ^*  (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^d MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

AGR2; Endoplasmic reticulum; p53; PDI; Secretome; Tumour

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

CARCINOGENESIS; HUMAN; METASTASIS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; TREATMENT RESPONSE;

AMINO ACID MOTIFS; ANDROGENS; ANIMALS; CARRIER PROTEINS; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM; ESTROGENS; EXTRACELLULAR FLUID; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIGENE FAMILY; NEOPLASM PROTEINS; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION MAPS; PROTEINS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84878015882     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.346     Document Type: Review

References (78)

1. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 2004; 4: 966-977.
2. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancerdisclaimer. Cancer Res 2007; 67: 10631-10634. (Pubitemid 350145884)
3. Chevet E, Cameron PH, Pelletier MF, Thomas DY, Bergeron JJ. The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation. Curr Opin Struct Biol 2001; 11: 120-124. (Pubitemid 32155561)
4. Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett 2007; 581: 3641-3651. (Pubitemid 47082516)
5. Benham AM. The protein disulfide isomerase family: key players in health and disease. Antioxid Redox Signal 2011; 16: 781-789.
6. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-698.
7. Kozlov G, Maattanen P, Thomas DY, Gehring K. A structural overview of the PDI family of proteins. FEBS J 2010; 277: 3924-3936.
8. Bradley L, Wainstock D, Sive H. Positive and negative signals modulate formation of the Xenopus cement gland. Development 1996; 122: 2739-2750. (Pubitemid 26326506)
9. Sive H, Bradley L. A sticky problem: the Xenopus cement gland as a paradigm for anteroposterior patterning. Dev Dyn 1996; 205: 265-280. (Pubitemid 26074004)
10. Aberger F, Weidinger G, Grunz H, Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev 1998; 72: 115-130. (Pubitemid 28186711)
11. Sive HL, Hattori K, Weintraub H. Progressive determination during formation of the anteroposterior axis in Xenopus laevis. Cell 1989; 58: 171-180. (Pubitemid 19180089)
12. Komiya T, Tanigawa Y, Hirohashi S. Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. Biochim Biophys Acta 1999; 1444: 434-438. (Pubitemid 29147317)
13. Adam GC, Sorensen EJ, Cravatt BF. Trifunctional chemical probes for the consolidated detection and identification of enzyme activities from complex proteomes. Mol Cell Proteomics 2002; 1: 828-835.
14. Adam GC, Sorensen EJ, Cravatt BF. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat Biotechnol 2002; 20: 805-809. (Pubitemid 34836757)
15. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 2003; 278: 6482-6489. (Pubitemid 36800908)
16. Gray TA, Maclaine NJ, Michie CO, Bouchalova P, Murray E, Howie J et al. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. J Immunol Methods 2012; 378: 20-32.
17. Xu X, Hou Y, Yin X, Bao L, Tang A, Song L et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012; 148: 886-895.
18. Persson S, Rosenquist M, Knoblach B, Khosravi-Far R, Sommarin M, Michalak M. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Mol Phylogenet Evol 2005; 36: 734-740. (Pubitemid 41138906)
19. Alanen HI, Williamson RA, Howard MJ, Lappi AK, Jantti HP, Rautio SM et al. Functional characterization of ERp18, a new endoplasmic reticulum-located thioredoxin superfamily member. J Biol Chem 2003; 278: 28912-28920. (Pubitemid 36935801)
20. Knoblach B, Keller BO, Groenendyk J, Aldred S, Zheng J, Lemire BD et al. ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins. Mol Cell Proteomics 2003; 2: 1104-1019.
21. Jessop CE, Watkins RH, Simmons JJ, Tasab M, Bulleid NJ. Protein disulphide isomerase family members show distinct substrate specificity: P5 is targeted to BiP client proteins. J Cell Sci 2009; 122: 4287-4295.
22. Anelli T, Alessio M, Mezghrani A, Simmen T, Talamo F, Bachi A et al. ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family. EMBO J 2002; 21: 835-844. (Pubitemid 34174063)
23. Bambang IF, Lee YK, Richardson DR, Zhang D. Endoplasmic reticulum protein regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells. Oncogene 2013; 32: 1240-1251.
24. Zhang JS, Gong A, Cheville JC, Smith DI, Young CY. AGR2an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005; 43: 249-259. (Pubitemid 40726870)
25. Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun 2006; 7: 11-18.
26. Petek E, Windpassinger C, Egger H, Kroisel PM, Wagner K. Localization of the human anterior gradient-2 gene (AGR2) to chromosome band 7p21. 3 by radiation hybrid mapping and fluorescence in situ hybridisation. Cytogenet Cell Genet 2000; 89: 141-142.
27. Krig SR, Jin VX, Bieda MC, O'Geen H, Yaswen P, Green R et al. Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays. J Biol Chem 2007; 282: 9703-9712. (Pubitemid 47104577)
28. Thompson DA, McPherson LA, Carmeci C, deConinck EC, Weigel RJ. Identification of two estrogen receptor transcripts with novel 5' exons isolated from a MCF7 cDNA library. J Steroid Biochem Mol Biol 1997; 62: 143-153. (Pubitemid 27475141)
29. Wilson CL, Sims AH, Howell A, Miller CJ, Clarke RB. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer 2006; 13: 617-628. (Pubitemid 43886681)
30. Zweitzig DR, Smirnov DA, Connelly MC, Terstappen LW, O'Hara SM, Moran E. Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol Cell Biochem 2007; 306: 255-260. (Pubitemid 350001838)
31. Higa A, Mulot A, Delom F, Bouchecareilh M, Nguyen DT, Boismenu D et al. Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. J Biol Chem 2011; 286: 44855-44868.
32. Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S et al. The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifentreated breast cancers. Oncogene 2010; 29: 4838-4847.
33. Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci USA 2009; 106: 6950-6955.
34. Tachibana C, Stevens TH. The yeast EUG1 gene encodes an endoplasmic reticulum protein that is functionally related to protein disulfide isomerase. Mol Cell Biol 1992; 12: 4601-4611.
35. Norgaard P, Winther JR. Mutation of yeast Eug1p CXXS active sites to CXXC results in a dramatic increase in protein disulphide isomerase activity. Biochem J 2001; 358: 269-274. (Pubitemid 32778123)
36. Wunderlich M, Otto A, Maskos K, Mucke M, Seckler R, Glockshuber R. Efficient catalysis of disulfide formation during protein folding with a single active-site cysteine. J Mol Biol 1995; 247: 28-33.
37. Zhao F, Edwards R, Dizon D, Afrasiabi K, Mastroianni JR, Geyfman M et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice. Dev Biol 2010; 338: 270-279.
38. Schroeder BW, Verhaeghe C, Park SW, Nguyenvu LT, Huang X, Zhen G et al. AGR2 is induced in asthma and promotes allergen-induced mucin overproduction. Am J Respir Cell Mol Biol 2012; 47: 178-185.
39. Li S, Wang Y, Zhang Y, Lu MM, Demayo FJ, Dekker JD et al. Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2. Development 2012; 139: 2500-2509.
40. Gupta A, Dong A, Lowe AW. AGR2 gene function requires a unique endoplasmic reticulum localization motif. J Biol Chem 2012; 287: 4773-4782.
41. Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, Iacobuzio- Donahue CA et al. AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res 2011; 71: 7091-7102.
42. Raykhel I, Alanen H, Salo K, Jurvansuu J, Nguyen VD, Latva-Ranta M et al. A molecular specificity code for the three mammalian KDEL receptors. J Cell Biol 2007; 179: 1193-1204. (Pubitemid 350277738)
43. Ramachandran V, Arumugam T, Wang H, Logsdon CD. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res 2008; 68: 7811-7818.
44. Fourtouna A, Murray E, Nicholson J, Maslon M, Pang L, Dryden D et al. The anterior gradient-2 Pathway as a model for developing peptide-aptamer anticancer drug leads that stimulate p53 function. Current Chemical Biology 2009; 3: 124-137.
45. Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, Ross P et al. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics 2004; 3: 534-547. (Pubitemid 38878513)
46. Dong A, Gupta A, Pai RK, Tun M, Lowe AW. The human adenocarcinoma- associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation. J Biol Chem 2011; 286: 18301-18310.
47. Maslon MM, Hrstka R, Vojtesek B, Hupp TR. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin. J Mol Biol 2010; 404: 418-438.
48. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 2005; 65: 3796-3805. (Pubitemid 40616358)
49. Kumar A, Godwin JW, Gates PB, Garza-Garcia AA, Brockes JP. Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science 2007; 318: 772-777. (Pubitemid 351411765)
50. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4. 4a and dystroglycan. Br J Cancer 2003; 88: 579-85. (Pubitemid 36363368)
51. Takenaka IM, Leung SM, McAndrew SJ, Brown JP, Hightower LE. Hsc70-binding peptides selected from a phage display peptide library that resemble organellar targeting sequences. J Biol Chem 1995; 270: 19839-19844.
52. Clarke DJ, Murray E, Hupp T, Mackay CL, Langridge-Smith PR. Mapping a noncovalent protein-peptide interface by top-down FTICR mass spectrometry using electron capture dissociation. J Am Soc Mass Spectrom 2011; 22: 1432-1440.
53. Fraser JA, Vojtesek B, Hupp TR. A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function. J Biol Chem 2010; 285: 37762-37672.
54. Worrall EG, Worrall L, Blackburn E, Walkinshaw M, Hupp TR. The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2. J Mol Biol 2010; 398: 414-428.
55. Worrall EG, Wawrzynow B, Worrall L, Walkinshaw M, Ball KL, Hupp TR. Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif. J Chem Biol 2009; 2: 113-129.
56. Fischer PM, Zhelev NZ, Wang S, Melville JE, Fahraeus R, Lane DP. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 2000; 55: 163-172. (Pubitemid 30079933)
57. Tian C, Gao P, Zheng Y, Yue W, Wang X, Jin H et al. Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death. Cell Res 2008; 18: 458-471. (Pubitemid 351498853)
58. Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J et al. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res 2010; 12: R32.
59. Wang Z, Hao Y, Lowe AW. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res 2008; 68: 492-497. (Pubitemid 351380076)
60. Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA et al. A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res 2008; 10: R88.
61. Hengel SM, Murray E, Langdon S, Hayward L, O'Donoghue J, Panchaud A et al. Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance. J Proteome Res 2011; 10: 4567-4578.
62. Varghese S, Lao-Sirieix P, Fitzgerald RC. Identification and clinical implementation of biomarkers for Barrett's esophagus. Gastroenterology 2012; 142: 435-441.
63. Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011; 145: 1023-1035.
64. Thompson DA, Weigel RJ. hAG-2 the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun 1998; 251: 111-1116.
65. Lepreux S, Bioulac-Sage P, Chevet E. Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree. Liver Int 2011; 31: 322-328.
66. Vivekanandan P, Micchelli ST, Torbenson M. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas. Hum Pathol 2009; 40: 293-299.
67. Komuta M, Govaere O, Vandecaveye V, Akiba J, Van Steenbergen W, Verslype C et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology 2012; 55: 1876-1888.
68. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54-61. (Pubitemid 46067386)
69. Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 2008; 15: 1499-1509.
70. Park K, Chung YJ, So H, Kim K, Park J, Oh M et al. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med 2011; 43: 91-100.
71. Sweeny L, Liu Z, Bush BD, Hartman Y, Zhou T, Rosenthal EL. CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma. Exp Cell Res 2012; 318: 1788-1798.
72. Zhang Y, Ali TZ, Zhou H, D'Souza DR, Lu Y, Jaffe J et al. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res 2010; 70: 240-248.
73. Bu H, Bormann S, Schafer G, Horninger W, Massoner P, Neeb A et al. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 2011; 71: 575-587.
74. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715. (Pubitemid 351636299)
75. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-746. (Pubitemid 37487967)
76. Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Sayan AE, Berx G et al. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 2007; 18: 4615-4624. (Pubitemid 350060186)
77. Zeng Q, Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 2008; 13: 188-192. (Pubitemid 351318373)
78. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008; 39: 1582-1589.